EAN News

EJoN publishes EAN consensus statement for management of patients with neurological diseases during the COVID‐19 pandemic

External Interview: Prof. Dafin Muresanu, Chair of the EAN Communication Committee, interviews Prof. Jean-Antoine Girault, President of FENS – Federation of European Neuroscience Societies

October's Executive Page: Prof. Riccardo Soffietti

For October 2020, we have selected the following Research paper: Livingston G. et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.

October's contribution to the Country of the Month: Serbia

We would like to congratulate the winners of this year’s Investigator Award.

It is with great grief that we announce the loss of our friend and mentor, Professor Ovidiu Alexandru Băjenaru. It would be difficult to write of our beloved colleague in these pages without betraying emotion. A brilliant neurologist, researcher, teacher, husband, father, he leaves behind a profound legacy of perhaps the most influential contemporary figure in Romanian neurology.

For September 2020, we have selected: The RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report.

David Vodušek, Chair of the EAN European Affairs sub-Committee interviews Wolfgang H. Oertel, member of the European Commission’s Scientific Panel for Health

Matthias Endres, new Member at Large By Matthias Endres Dear Colleagues and Friends, It is indeed a great honour for me to be elected as a new Member-at-Large of the EAN board. Especially in these times of great uncertainty both… Continue Reading

Kazakhstan, officially the Republic of Kazakhstan (Kazakh: Қазақстан Республикасы), is located in the centre of the Eurasian continent.

After careful consideration, EAN has decided to cancel the in-person version of the forthcoming Spring School due to take place next week.

Epilepsy care during the COVID-19 pandemic

Summer School Health and Wealth WEB Seminars – Converging pathways in Alzheimer and Parkinson’s disease: management strategies and disease modifying treatment

For August 2020, we have selected Turner R.S. et al. “Nilotinib Effects on Safety, Tolerability,and Biomarkers in Alzheimer’s Disease” Annals of Neurology 2020;88:183–194. doi: 10.1002/ana.25775. Epub 2020 May 28.